Cargando…
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease
Axonal degeneration is one of the earliest features of Parkinson’s disease pathology, which is followed by neuronal death in the substantia nigra and other parts of the brain. Inhibition of axonal degeneration combined with cellular neuroprotection therefore seem key to targeting an early stage in P...
Autores principales: | Tönges, Lars, Frank, Tobias, Tatenhorst, Lars, Saal, Kim A., Koch, Jan C., Szegő, Éva M., Bähr, Mathias, Weishaupt, Jochen H., Lingor, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501973/ https://www.ncbi.nlm.nih.gov/pubmed/23087045 http://dx.doi.org/10.1093/brain/aws254 |
Ejemplares similares
-
Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease
por: Tönges, Lars, et al.
Publicado: (2014) -
ROCKing Regeneration: Rho Kinase Inhibition as Molecular Target for Neurorestoration
por: Tönges, Lars, et al.
Publicado: (2011) -
Viral vector-mediated downregulation of RhoA increases survival and axonal regeneration of retinal ganglion cells
por: Koch, Jan Christoph, et al.
Publicado: (2014) -
The rho kinase inhibitor Y-27632 improves motor performance in male SOD1(G93A) mice
por: Günther, René, et al.
Publicado: (2014) -
Axonal degeneration as a therapeutic target in the CNS
por: Lingor, Paul, et al.
Publicado: (2012)